source
- Experts review expanding role of radiopharmaceuticals in metastatic castration-resistant prostate cancerDr. Pedro Barata and Dr. Johann De Bono open a discussion on the evolving role of radiopharmaceuticals in metastatic castration-resistant prostate cancer (mCRPC). They describe how these agents ar…
- Experts discuss why anti-CCR8 antibody denikitug is being tested in phase 1 solid tumor trialsDr Bruno B. Bockorny, a gastrointestinal oncologist at Beth Israel Deaconess Medical Center and assistant professor at Harvard Medical School, explained the scientific basis for testing the anti‑CC…